S&P 500

5.222,68

0,16%

Aumente o nível de sua negociação com nossas ferramentas poderosas e insights em tempo real, tudo em um só lugar.

Cadastre-se

Início
Investir
Ações
EUA
AMEX
IsoRay Inc (ISR)
IsoRay Inc (ISR) Notícias

ISR

IsoRay (ISR)

IsoRay Inc

De:

Notícias regulamentadas

Procure um Texto:

Ordenação:

Notícias não regulamentadas

Apresentando as notícias mais relevantes sobre:AMEX:ISR

1 2 3 4 5 6 7 Próxima >>

Data	Hora	Fonte	Título	Código	Companhia
24/04/2024	17:35	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	AMEX:ISR	IsoRay Inc
19/04/2024	17:05	Edgar (US Regulatory)	Form SC 13G - Statement of acquisition of beneficial ownership by individuals	AMEX:ISR	IsoRay Inc
18/04/2024	17:11	Edgar (US Regulatory)	Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material	AMEX:ISR	IsoRay Inc
18/04/2024	17:09	Edgar (US Regulatory)	Form DEF 14A - Other definitive proxy statements	AMEX:ISR	IsoRay Inc
16/04/2024	17:05	Edgar (US Regulatory)	Form 8-K - Current report	AMEX:ISR	IsoRay Inc
10/04/2024	01:15	Edgar (US Regulatory)	Form EFFECT - Notice of Effectiveness	AMEX:ISR	IsoRay Inc
09/04/2024	17:25	Edgar (US Regulatory)	Form 424B3 - Prospectus [Rule 424(b)(3)]	AMEX:ISR	IsoRay Inc
08/04/2024	17:12	Edgar (US Regulatory)	Form PRE 14A - Other preliminary proxy statements	AMEX:ISR	IsoRay Inc
01/04/2024	08:46	Edgar (US Regulatory)	Form S-8 - Securities to be offered to employees in employee benefit plans	AMEX:ISR	IsoRay Inc
29/03/2024	08:35	Edgar (US Regulatory)	Form S-3 - Registration statement under Securities Act of 1933	AMEX:ISR	IsoRay Inc
28/03/2024	09:34	Edgar (US Regulatory)	Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]	AMEX:ISR	IsoRay Inc
18/03/2024	17:18	Edgar (US Regulatory)	Form D - Notice of Exempt Offering of Securities	AMEX:ISR	IsoRay Inc
08/03/2024	13:22	Edgar (US Regulatory)	Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]	AMEX:ISR	IsoRay Inc
05/02/2024	21:18	Edgar (US Regulatory)	Form SCHEDULE 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]	AMEX:ISR	IsoRay Inc
01/02/2024	09:56	Edgar (US Regulatory)	Form 3 - Initial statement of beneficial ownership of securities	AMEX:ISR	IsoRay Inc
01/02/2024	09:38	Edgar (US Regulatory)	Form SC 13D - General statement of acquisition of beneficial ownership	AMEX:ISR	IsoRay Inc
18/01/2024	18:49	Edgar (US Regulatory)	Form 424B5 - Prospectus [Rule 424(b)(5)]	AMEX:ISR	IsoRay Inc
17/01/2024	15:40	Edgar (US Regulatory)	Form 8-K/A - Current report: [Amend]	AMEX:ISR	IsoRay Inc
14/11/2023	18:59	Edgar (US Regulatory)	Form 10-Q - Quarterly report [Sections 13 or 15(d)]	AMEX:ISR	IsoRay Inc
14/06/2023	17:46	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	AMEX:ISR	IsoRay Inc
14/06/2023	17:42	Edgar (US Regulatory)	Specialized Disclosure Report (sd)	AMEX:ISR	IsoRay Inc
15/05/2023	18:23	Edgar (US Regulatory)	Quarterly Report (10-q)	AMEX:ISR	IsoRay Inc
15/05/2023	18:16	Edgar (US Regulatory)	Current Report Filing (8-k)	AMEX:ISR	IsoRay Inc
01/05/2023	18:04	Edgar (US Regulatory)	Annual Transition Report (10-kt)	AMEX:ISR	IsoRay Inc
17/03/2023	18:09	Edgar (US Regulatory)	Initial Statement of Beneficial Ownership (3)	AMEX:ISR	IsoRay Inc
08/03/2023	09:30	GlobeNewswire Inc.	Perspective Therapeutics Announces the Awarding of a $1 million Collaborative Grant to King’s College London to Support Radiobiology Research of Alpha Particle Therapy for Cancer	AMEX:ISR	IsoRay Inc
22/02/2023	19:02	GlobeNewswire Inc.	Initial Results From First Patient Dosed With Perspective Therapeutics’ Lead Drug VMT-α-NET Presented at The Treatment of Neuroendocrine Disorders at the 2023 PET/RTRC Annual Workshop Scientific Session	AMEX:ISR	IsoRay Inc
21/02/2023	08:02	Edgar (US Regulatory)	Small Company Offering and Sale of Securities Without Registration (d)	AMEX:ISR	IsoRay Inc
16/02/2023	18:05	GlobeNewswire Inc.	Perspective Therapeutics (formerly known as Isoray, Inc.) Announces Financial Results for the Quarter ended December 31, 2022	AMEX:ISR	IsoRay Inc
07/02/2023	19:48	GlobeNewswire Inc.	Isoray Inc. and Viewpoint Molecular Targeting Inc. Announce Name Change to Perspective Therapeutics Inc.	AMEX:ISR	IsoRay Inc